Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty-controlled motion components and systems for various industries in the United States, Canada, South America, Europe,…
FAIL · Does not pass the screen
95.69 USD
At the last full screen 2026-08-27
Screened 2026-08-27 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its distribution label.
Allient Inc. holds its Distribution at $95.69. Elevated stress, defensive posture warranted, held for 82 days.
As held on the ledger · 2026-08-27
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 82 days
Price at the screen
$95.69
Valuation
56.29 trailing · 28.83 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.62
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
35.08%
Below 33%
Interest-bearing debt is 35.1% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
22.42%
Below 49%
Money owed to the company is 22.4% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-08-27 screen. The gold marker is the market price at the same screen. A 10.4% margin of safety to the base estimate.
Third-party analyst targets: 5 covering, consensus Buy. The average target sits +31% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Precision parts priced well beyond their pace
Every factory line that needs a motor to turn at exactly the right speed ends up buying something from Allient. Yet the company is growing revenue at just 5 percent a year while posting a 4 percent profit margin and an 8 percent return on equity. At 28.3 times forward earnings the shares sit 11 percent above our fair value, a gap the analyst consensus target of 75 dollars also flags.
This leaves no opportunity. The business clears our ethical screen, but the numbers show thin returns and modest growth being asked to support a premium multiple that the rest of the market has already started to question.
Valuation risk is the main concern here. If growth stays in the mid-single digits and margins do not lift, the current price leaves little room for error and plenty of scope for disappointment. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ALNT trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-21Markup$114.28+30.4%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 30.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 151%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (5 analysts) rates it buy, with a mean price target of $74.
2026-07-21Markup$87.67-4.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 151%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (5 analysts) rates it buy, with a mean price target of $74.
2026-07-18Markup$91.37+0.0%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 151%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (5 analysts) rates it buy, with a mean price target of $74.
2026-07-17Markup$91.37+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 151%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (5 analysts) rates it buy, with a mean price target of $74.
2026-07-03Markup$91.37+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$91.37Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
